Department of Infection and Tropical Medicine, Birmingham Heartlands Hospital, Birmingham, UK; National Infection Service, Public Health England, Colindale, London, UK.
National Infection Service, Public Health England, Colindale, London, UK.
Clin Microbiol Infect. 2018 Nov;24(11):1164-1170. doi: 10.1016/j.cmi.2018.04.027. Epub 2018 May 25.
Mycobacterium chimaera infection following cardiac surgery, due to contaminated cardiopulmonary bypass heater-cooler units, has been reported worldwide. However, the spectrum of clinical disease remains poorly understood. To address this, we report the clinical and laboratory features, treatment and outcome of the first 30 UK cases.
Case note review was performed for cases identified retrospectively through outbreak investigations and prospectively through ongoing surveillance. Case definition was Mycobacterium chimaera detected in any clinical specimen, history of cardiothoracic surgery with cardiopulmonary bypass, and compatible clinical presentation.
Thirty patients were identified (28 with prosthetic material) exhibiting a spectrum of disease including prosthetic valve endocarditis (14/30), sternal wound infection (2/30), aortic graft infection (4/30) and disseminated (non-cardiac) disease (10/30). Patients presented a median of 14 months post surgery (maximum 5 years) most commonly complaining of fever and weight loss. Investigations frequently revealed lymphopenia, thrombocytopenia, liver cholestasis and non-necrotizing granulomatous inflammation. Diagnostic sensitivity for a single mycobacterial blood culture was 68% but increased if multiple samples were sent. In all, 27 patients started macrolide-based combination treatment and 14 had further surgery. To date, 18 patients have died (60%) a median of 30 months (interquartile range 20-39 months) after initial surgery. Survival analysis identified younger age, mitral valve surgery, mechanical valve replacement, higher serum sodium concentration and lower C-reactive protein as factors associated with better survival.
Mycobacterium chimaera infection following cardiac surgery is associated with a wide spectrum of disease. The diagnosis should be considered in all patients who develop an unexplained illness following cardiac surgery.
由于被污染的体外循环热交换器,在心脏手术后感染分枝杆菌 chimaera 的病例已在全球范围内报道。然而,其临床表现仍知之甚少。为了解决这个问题,我们报告了英国的前 30 例病例的临床和实验室特征、治疗和结果。
通过回顾性暴发调查和前瞻性监测,对病例进行病例记录回顾。病例定义为在任何临床标本中检测到分枝杆菌 chimaera、有体外循环心脏手术史以及有符合的临床表现。
确定了 30 例患者(28 例有假体材料),表现出多种疾病,包括人工瓣膜心内膜炎(14/30)、胸骨伤口感染(2/30)、主动脉移植物感染(4/30)和播散性(非心脏)疾病(10/30)。患者在手术后中位时间 14 个月(最长 5 年)出现症状,最常见的表现为发热和体重减轻。检查结果常显示淋巴细胞减少、血小板减少、肝胆汁淤积和非坏死性肉芽肿性炎症。单次分枝杆菌血培养的诊断敏感性为 68%,但如果多份样本送检则会增加。总共 27 例患者开始使用大环内酯类药物联合治疗,14 例患者进一步手术。到目前为止,18 例患者死亡(60%),中位时间为初始手术后 30 个月(四分位间距 20-39 个月)。生存分析确定年龄较小、二尖瓣手术、机械瓣膜置换、血清钠浓度较高和 C 反应蛋白较低与更好的生存相关。
心脏手术后感染分枝杆菌 chimaera 与广泛的疾病谱相关。所有在心脏手术后出现不明原因疾病的患者都应考虑该诊断。